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Localization of sentinel lymph nodes can be challenging if they
are in difficult anatomic locations or near high radiotracer
activity. The purpose of this study was to assess the value of
intraoperative real-time imaging using a portable g-camera in
conjunction with a conventional g-counting probe when it is
difficult to localize the sentinel node. Methods: After 99mTc-
nanocolloid injection, patients with various malignancies under-
went presurgical lymphoscintigraphy followed by surgery (usu-
ally the next day). We evaluated 20 patients who required
sentinel lymph node biopsy and in whom the location or other
characteristics of the sentinel node would make intraoperative
retrieval difficult. During surgery, the sentinel node was local-
ized using a portable g-camera together with a hand-held
g-probe. A 153Gd pointer or 125I seed was used to better depict
the sentinel node location in real time. Results: Using only a
conventional hand-held g-probe, surgeons were able to defin-
itively localize the sentinel node in 15 of 20 patients. Intraoper-
atively, the portable g-camera showed uptake by the definite
sentinel node in 19 of 20 patients and helped to precisely local-
ize the node with the hand-held g-probe in 4 patients. In 1 of
these patients, the sentinel node was metastatic. Conclusion:
The combination of a standard hand-held g-probe and real-time
imaging provided by a portable g-camera offers a high intra-
operative detection rate in patients with difficult sentinel node
localization as assessed by presurgical lymphoscintigraphy.
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The sentinel lymph node procedure was introduced in
the 1990s as a staging technique replacing the then-stand-
ard procedure, complete regional lymphadenectomy. The
new procedure was validated for malignancies such as mel-
anoma and breast cancer, came into routine clinical use for
such malignancies, and is still the standard of care in their
initial stages (1–4).
Over time, as the technique evolved, this procedure came
into use for other malignancies, such as penile, vulvar, and
head and neck cancers. In all these tumors, lymphatic
drainage can be characterized as predominantly superficial,
and sentinel nodes can be successfully mapped by means of
preoperative lymphoscintigraphy and the intraoperative use
of a hand-held g-probe or vital dye (5–7). However, the
localization of sentinel nodes presents difficulties in some
lymphatic basins of the neck in patients with head and neck
cancer or melanoma. Also, sentinel nodes outside the axilla
in breast cancer patients are sometimes difficult to retrieve.
Although conventional lymphoscintigraphy plays a pivotal
role in the depiction of drainage areas and a hand-held
g-probe is used to intraoperatively assess the location of
the sentinel node, its position cannot always be clearly
identified, potentially producing misleading results (8,9).
New devices have been developed to deal with the
limitations of planar lymphoscintigraphy and hand-held
g-probes. One important advance is the introduction of
hybrid imaging devices such as SPECT/CT. SPECT/CT
images, which clearly depict the sentinel nodes within an
anatomic landscape, can provide a useful road map for
surgeons (10,11). Probably the most important contribution
of SPECT/CT will be for those tumors with deeper drain-
age, such as gastrointestinal, gynecologic, and urologic
malignancies (12).
Recently, there have been several reports on the use of
portable g-cameras in clinical and experimental settings
(13–18). These devices play a remarkable role in the incorpo-
ration of imaging during surgery and can be combinedwith the
information obtained preoperatively by lymphoscintigraphy
or, even better, with information from previously performed
SPECT/CT. Using the anatomic landmarks of SPECT/CT
images, the portable device can be oriented to surgical targets
in the operating room. Moreover, the possibility of obtaining a
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real-time image can be helpful to the surgeon, resulting in
more reliable and, probably, briefer surgery, especially when
the sentinel node is in a difficult anatomic area or near the
radiotracer injection point (18–20).
The aim of the current study was to evaluate the use of a
portable g-camera during surgery. The included cases were
rated difficult as judged by the nuclear physician and sur-
geon on the basis of the preoperative lymphoscintigraphy
findings and the expected extended surgery time.
MATERIALS AND METHODS
Patients
From September 2008 to September 2009, we performed 210
sentinel lymph node procedures on melanoma, breast, and
gynecologic cancers. Twenty of these cases had sentinel nodes
that were rated as difficult to localize. This rating was based on the
preoperative lymphoscintigraphy findings (weak uptake, nodes
near the injection site, unclear locations, cluster of nodes), the
nuclear physician’s and surgeon’s experience with the procedure,
and their judgment of which cases might prove to require extended
surgery time.
The data and characteristics of the 20 patients are listed in Table
1. Patients were included in this study if preoperative imaging
showed a sentinel node. When no node was visualized during pre-
surgical lymphoscintigraphy, patients were excluded from this eval-
uation. These patients had been diagnosed with malignant
melanoma (5 patients), breast cancer (9 patients), and gynecologic
cancer (6 patients).
Presurgical Sentinel Node Localization
All patients underwent preoperative lymphoscintigraphy after
injection of 111 MBq of 99mTc-nanocolloid (GE Healthcare). In
melanoma and vulvar cancer patients, the tracer was injected
intradermally, around the biopsy scar, in 4 deposits of 0.1 mL
(0.4 mL total). In breast cancer patients, the tracer was adminis-
tered intratumorally, in volumes of 0.5 or 0.3 mL. The volume
used depended on whether a tumor was palpable (0.5 mL) or
nonpalpable (0.3 mL). In nonpalpable lesions, radiotracer was
injected under ultrasonographic guidance. For gynecologic cancer
patients, nanocolloidal particles were injected perilesionally. In
cervical cancer patients, a volume of 2 mL was divided into 4
deposits of 0.5 mL each. In uterine cancer patients, the tracer was
placed in anterior and posterior uterine walls, with transvaginal
ultrasound guidance, in 2 deposits of 4 mL each (8 mL total).
After tracer injection, preoperative lymphoscintigraphy was
performed on all patients. In patients with malignant melanoma, a
dynamic study (128 · 128 matrix, 20 images, 30 s/image) was
performed. Planar images were acquired in all cases at 30 min and
2 h after radiotracer injection. In some cases, a late image (4–6 h)
was obtained.
Once delayed planar images were finished, SPECT (128 · 128
matrix, 120 frames, 15 s/frame) and low-dose CT (512 · 512
matrix, 140 kV, 2.5 mAs) were acquired, using a hybrid camera
(Infinia Hawkeye 4; GE Healthcare).
After processing of raw images and correction for attenuation
and scatter, corresponding SPECT and CT 4.5-mm slices were
generated in a Xeleris workstation (GE Healthcare). Images were
fused using the appropriate workstation software and correctly
analyzed using 2-dimensional reslicing in axial, coronal, and
sagittal views.
From the scintigraphic point of view, sentinel nodes were those
considered to be the first to appear in the dynamic study or in the
sequential images in a specific lymph node basin, those directly
connected with the injection zone by a lymphatic channel, or those
meeting a combination of these criteria. Nodes appearing later in
the same lymphatic stations were considered to be second-echelon
nodes. If SPECT/CT demonstrated more hot spots in other areas
with no other drainage or in zones closer to the injection site but
without visualization on the planar images, those hot spots were
also considered sentinel nodes. The location of the sentinel node
was marked on the skin with an indelible-ink pen.
Intrasurgical Sentinel Node Localization
Surgery took place the day after the lymphoscintigraphic study,
18–20 h after tracer injection. Sentinel nodes were removed using
the traditional approach in melanoma and breast cancer patients
and laparoscopically in gynecologic cases, except for vulvar
cancer.
For intraoperative sentinel node localization, a hand-held
g-probe (Navigator; USCC) was used (with a probe of 11–14
mm in cases of melanoma, breast cancer, and vulvar cancer and
a laparoscopic probe of 11-mm diameter in cases of uterine and
cervical cancer).
We used, in combination with the g-probe, a portable g-camera
(Sentinella S102; GEM Imaging) fitted with a 4-mm pinhole col-
limator with a field of view of 4 · 4 cm. This field of view
increases to 20 · 20 cm when the camera is placed 18 cm from
the patient’s body.
In melanoma, breast cancer, and vulvar cancer, a 153Gd pointer
was used to better locate the sentinel node on the g-camera screen.
This pointer was introduced in a surgical glove, and during the
operation the pointer was displayed separately (as a green circle)
on the portable g-camera screen. In laparoscopic procedures, we
used as a pointer a 125I seed attached to the tip of a surgical
grasper. The portable g-camera was sterile-draped in such a way
as to allow placement and movement above and within the surgi-
cal field. During each surgery, a first image of 60–120 s was
acquired to assess the surgical field and validate sentinel node
uptake. After incision, the hand-held g-probe was introduced into
the wound to locate the sentinel node. If there was any difficulty in
finding the precise location of the sentinel node using the g-probe
(more than 5 min), another image of 60–120 s was acquired using
the portable g-camera. Then, the surgeon placed the g-camera
above the previously marked sentinel node locations using the
laser pointer fitted to the g-camera and using the appropriate
pointer depending on the case. The laser pointer is included in
the supporting g-camera structure and displays a red cross over the
patient’s skin. The position of this red cross is visible on the
computer screen of the equipment. During surgery, the matching
of 2 signals (99mTc signal and 153Gd or 125I pointer signals)
showed the correct location of the sentinel nodes. This location
was then checked using the g-probe. After sentinel node retrieval,
another set of images was acquired to ascertain the absence, or
otherwise, of the previously visualized sentinel nodes or to ascer-
tain the presence, or otherwise, of second-tier nodes.
All hot spots close to the marked areas were considered to be
sentinel nodes. Second-echelon lymph nodes identified preoper-
atively were left in place. All sentinel nodes were sought using the
hand-held g-probe and the portable g-camera and were removed
wherever possible. All nodes were subsequently examined by
expert pathologists.
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RESULTS
Table 1 shows all sentinel nodes harvested, together with
their pathologic results.
In the melanoma group, 4 (80%) of 5 patients had a
primary lesion in the head region, and the remaining patient
had a lesion on a lower limb. Preoperative lymphoscintig-
raphy depicted at least 1 sentinel node in all cases. Two
patients presented with a submandibular sentinel node, and
2 others showed a complicated drainage pattern with many
nodes in occipital, preauricular, and cervical basins. Finally,
the patient with the primary malignant melanoma on the
lower limb presented with sentinel nodes in the popliteal
and inguinal regions, as well as an in-transit node in the mid
thigh (Fig. 1).
In this subgroup, when using only a hand-held g-probe,
surgeons were able to localize 12 sentinel nodes in 4 of 5
patients (80%) but with some difficulties. In 1 patient, dif-
ficulty was caused by the high number of lymph nodes
visualized on lymphoscintigraphy. In another patient, sig-
nificant activity in the scar made localization difficult when
only the probe was used. In this patient, an image acquired
using the portable g-camera helped facilitate excision of the
sentinel node (Fig. 2).
When the portable g-camera and the g-probe were used
together, surgeons were able to localize and excise addi-
tional nodes assumed to be sentinel. Images acquired with
the portable g-camera were acquired in less than 2 min; 5 or
fewer images were acquired in each case.
In the breast cancer group, of the 9 patients included in
the study, all but 1 presented with drainage to axillary
lymph nodes (89%). Six patients presented with drainage in
the inner mammary chain (67%), and 2 showed intra-
mammary sentinel nodes as well as axillary nodes (22%).
In this subgroup, a total of 22 sentinel nodes were
harvested: 12 axillary, 2 intramammary, and 8 in the inner
mammary chain. Using only the hand-held g-probe, sur-
geons correctly localized at least 1 sentinel node in each
patient. However, they did not find all nodes considered
sentinel in 2 (22%) of 9 patients. Sentinel node localization
with the g-probe alone was not totally successful in a
patient determined to have an intramammary node (Fig.
2) and in another patient observed to have inner mammary
chain nodes with weak uptake on preoperative lymphoscin-
tigraphy. On the other hand, when using the portable
g-camera with the g-probe, surgeons localized 22 sentinel
nodes. The mean time for localizing and harvesting sentinel
nodes was 10 min—that is, the time from which the sur-
geon decided that use of the counting probe alone was not
sufficient and began using the portable g-camera until the
time at which sentinel node retrieval was finished.
TABLE 1. Patient Characteristics and Results
Patient no. Age (y) Location Drainage SN harvested Time (min)* Pathology
Melanoma
1 50 Parietal Occipital/retro-SCM 2 occipital, 1 retro-SCM 10 Negative
2 45 Right lower limb Popliteal/inguinal 1 popliteal, 1 inguinal 6 Inguinal positive
3 71 Nose Submandibular 2 left submandibular,
2 right submandibular
10 Negative
4 36 Frontal Parotid 2 parotid, 1 preauricular,
1 SCM
10 Negative
5 65 Facial Submandibular 1 submandibular 5 Negative
Breast cancer
6 43 Right upper outer AX/IM 1 AX, 1 IM 10 IM positive
7 66 Left central lower AX/IMC 1 AX, 1 IMC 10 Negative
8 47 Right upper inner AX/IMC 2 AX, 2 IMC 20 Negative
9 63 Left upper innner AX/IM 1 AX, 1 IM 7 AX positive
10 47 Right upper inner AX/IMC 1 AX, 1 IMC 12 Negative
11 53 Left upper inner IMC 1 IMC 10 Negative
12 52 Right lower outer AX/IMC 2 AX, 1 IMC 10 Negative
13 49 Left central inner AX 2 AX 7 AX positive†
14 56 Left upper inner AX/IMC 2 AX, 2 IMC 14 Negative
Gynecologic
15 43 Cervix Left pelvic 1 external iliac 4 Negative
16 33 Cervix Bilateral pelvic 1 right hypogastric, 1 left
external iliac
7 Negative
17 69 Endometrium Right pelvic 1 obturator, 1 iliac 10 Obturator positive
18 37 Cervix Right pelvic 1 obturator, 1 parametrial 10 Obturator positive
19 66 Vulva (labia majora) Bilateral inguinal 2 right inguinal, 2 left obturator 5 Negative
20 34 Endometrium Right paraaortic 2 precaval 20 Negative
*Time to localize and excise sentinel node with g-camera and counting probe.
†Only 1 of 2 sentinel nodes was positive.
AX 5 axilla; SCM 5 sternocleidomastoid muscle; IM 5 intramammary; IMC 5 inner mammary chain; SN 5 sentinel lymph node.
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Overall, surgeons localized 19 of 22 harvested nodes
using only the hand-held g-probe. The other 3 harvested
nodes were localized using the portable g-camera and the
g-probe. Pathologic assessment of the nodes showed meta-
static involvement in 3 patients (33%). One of these showed
a 4-mm metastasis in the intramammary node localized by
the portable g-camera. No axillary lymphadenectomy was
performed, because the axillary sentinel node was negative
for metastasis.
The gynecologic malignancy group included 3 patients
with cervical cancer, 2 with endometrial tumor, and 1 with
vulvar melanoma (which we decided to include in this group
although it was a malignant melanoma). The lymphatic
drainage was pelvic in all cervical tumors, pelvic or para-
aortic in patients with endometrial cancer, and inguinal
in the patient with vulvar melanoma. Thirteen sentinel
nodes were excised in these patients, and the hand-held
laparoscopic and traditional g-probe clearly identified 10 of
them (77%). The portable g-camera showed definite sentinel
node uptake in 12 (92%) of these sentinel nodes and weak
activity in the remaining one. The cases in which the hand-
held g-probe had difficulty localizing the sentinel node were
1 right parametrial node close to the radiotracer administra-
tion point and 2 right precaval nodes that were masked by
high liver activity (Fig. 3). The time needed to localize the
lymph nodes was different between vulvar/cervical malig-
nancies and endometrial tumors (5–7 min and 15 min,
respectively).
In summary, using only the hand-held g-probe, surgeons
localized the sentinel nodes harvested in 15 (75%) of 20
patients. Surgeons using the portable g-camera and the
g-probe localized the sentinel nodes harvested in 19
(95%) of 20 patients. One node harvested after the use of
the g-camera was metastatic. This node might have been
missed if the camera had not been available during surgery.
The mean time required for localizing and harvesting sen-
FIGURE 1. Patient with malignant
melanoma on right heel. Preoperative
lymphoscintigraphy showed lymphatic
channels toward mid thigh and
inguinal region. SPECT/CT images
show superficial popliteal node (A);
portable g-camera was positioned
above this area with laser pointer
centered on skin mark (B), and these
images clearly demonstrate popliteal
uptake in vivo (C) and, after sentinel
node resection, absence of activity in
surgical field (D). SPECT/CT images
show deep localization of in-transit
sentinel node in mid thigh. When portable g-camera was imaging this area, tracer uptake could be seen. It was decided not
to retrieve this activity because of its depth and because popliteal sentinel node in same channel had been retrieved earlier.
FIGURE 2. (A–C) Patient with left
mandibular melanoma seen on
delayed image (A). During surgery,
surgeon using hand-held g-probe
could not precisely assess sentinel
node location because residual
activity was high even though wide
excision had been performed. Images
obtained with portable g-camera 10
cm from patient did not show sentinel
node (B), but in images acquired with
camera closer to selected area,
sentinel node (arrow) could be
distinguished from radiotracer area
(C). (D–F) Breast cancer patient with
lymphatic drainage to intramammary
and axillary nodes seen on pre-
operative image (D). Axillary sentinel
node was harvested without difficulty
with aid of hand-held g-probe.
However, intramammary node could
not be precisely located because of level of activity from primary tumor. Images obtained with real-time g-camera (E) better
depicted location of node (arrow) (F).
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tinel nodes with the portable g-camera was 10 min (range,
4–20 min).
DISCUSSION
Sentinel lymph node localization is a minimally invasive
procedure, but in some circumstances the search for and
removal of the correct node is challenging and time-
consuming (9).
This staging procedure has gained widespread use in
melanoma and breast cancer and is currently being
explored in many other malignancies (such as gynecologic
and urologic cancers) (21). Although the reported success
of sentinel node localization is high in most published stud-
ies, some node locations preclude a quick and easy
retrieval. These cases require longer than the usual surgical
time for localization and excision (22,23).
Several studies have demonstrated the complexity and
difficulty of excising head and neck sentinel nodes, with an
intraoperative excision rate ranging from 75% to 100%
(24–26). Another difficult aspect can be retrieval of in-
transit sentinel nodes, which in some circumstances appear
in rare locations (22,27). In all our patients in this setting,
sentinel nodes could be retrieved without much difficulty by
combining the hand-held g-probe with the guidance and
monitoring of the portable g-camera. However, when only
the probe was used, difficulties were experienced in 2
patients, one because of the presence of several nodes
and the other because of the high activity remaining after
wide local excision. These kinds of complications are
known pitfalls in the interpretation of presurgical lympho-
scintigraphy and in intraoperative localization. The surgical
time used to localize and harvest the sentinel nodes in this
group averaged 10 min.
In breast cancer patients, the situation can be especially
difficult when intramammary or inner mammary chain
nodes are observed or when lymph nodes are near the
injection site (28–30). Most of these situations can now be
resolved by a presurgical lymphoscintigraphic study with
the aid of SPECT/CT (31). However, in the operating room,
the method based on blue dye or the hand-held g-probe can
be misleading because of an absence of blue coloration, the
presence of only faint uptake of tracer, or the presence of
significant emission and scatter from the injection site. We
encountered all these difficulties in our group of patients. In
some, we were unable to adequately depict all sentinel
nodes using only the hand-held g-probe in difficult scenar-
ios such as when one or more sentinel nodes were in intra-
mammary or inner mammary chains. Real-time images
acquired with the portable g-camera were successfully used
to find sentinel nodes that had been missed when only the
g-probe was used. Importantly, 1 node not found using the
probe alone was positive for metastasis, and although no
axillary lymphadenectomy was performed, this node was
determinant in staging the disease. Mathelin et al. (32)
evaluated the performance of an intraoperative g-camera
in the detection of axillary drainage and the assessment
of sentinel node removal in 25 breast cancer patients. In
1 patient, this device allowed the detection of a residual
sentinel node with low activity, which was massively meta-
static. Soluri et al. (33) showed good results with a portable
g-camera in 30 breast cancer patients, with the advantage of
an intraoperative-time reduction of 7 min, and surgeons
considered the use of the portable g-camera very useful
in 8 of 30 patients.
A high percentage of medial-quadrant tumors drain to
the inner mammary chain, and hand-held probes cannot
discriminate tumor activity from activity emitted by a tiny
node in a deep intercostal region or behind a rib (34,35).
The possibility of identifying this space is a real advantage
to the use of a portable g-camera over the use of only a
g-counting probe, as intraoperative images can depict with
reasonable precision the intercostal localization of a senti-
nel node.
Reported rates of intraoperative sentinel node identifica-
tion are excellent in vulvar cancer and quite good in
cervical cancer, ranging from 75% to 100% (36). Sentinel
node identification in endometrial cancer shows wide var-
iation due to a lack of standardization of the procedure,
with localization rates ranging from 50% to 100% (37).
Intraoperative difficulties are similar in the deep-drainage
cancers, such as cervical and uterine cancers, in which
sentinel nodes are near the injection site (parametrial nodes
in cervical cancer) or outside the normal lymphadenectomy
area (paraaortic nodes) (38).
FIGURE 3. Patient with endometrial carcinoma and
drainage to paraaortic region seen on preoperative image
(A). During surgery, detection of sentinel node with hand-
held g-probe was hampered by liver activity. Portable
g-camera was used to locate node (B). Portable g-camera
real-time images (C) were definitive in retrieval of this node
(arrow) by matching 125I seed (circle) with node activity (D).
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In our series, there were no significant differences
between the g-probe and the g-camera in vulvar cancer.
The portable g-camera was used to monitor the pelvic area
before and after removal of the hot nodes, to assess whether
the sentinel node had been removed and to determine
whether additional nodes or only background activity
remained. This information is especially important in lap-
aroscopic procedures, in which spatial mobility is limited
and probe handling is not always easy. In this sense,
Vermeeren et al. (39) showed the feasibility of using a
portable g-camera in urologic malignancies in 20 patients,
with intraoperative identification in 90% of the patients,
and raised the possibility of extending its use to other
deep-draining malignancies.
Finally, the additional acquisition of several real-time
images implies that surgical time must accommodate
imaging time. In our study, the time for imaging may or
may not be an actual addition to the surgical time, relative
to a procedure in which no portable camera is used. If the
portable camera is not used, a surgeon may need to spend a
significant amount of time seeking additional nodes or
confirming that no more are likely to be found. However,
even if additional time is needed, our short series suggests
that this extra time may have sufficient usefulness in the
context of sentinel node procedures that are likely to be
difficult, as the use of the g-camera might reduce the pos-
sibility of missing a malignant sentinel node.
We are aware that this limited study describes the most
complicated scenarios that can be observed when using the
traditional approach with a hand-held g-probe for sentinel
lymph node localization. The current possibility of using
tomographic and fused images preoperatively offers valua-
ble information to the surgeon for the planning of appro-
priate surgery in each case. The introduction of a portable
g-camera for intraoperative guidance and real-time imaging
is the next step to refining, as much as possible, the feasi-
bility of the sentinel node technique in most tumors
reported.
CONCLUSION
Our results in this particular series suggest that real-time
imaging with a portable g-camera in combination with a
traditional g-counting probe results in high detection and
localization of sentinel nodes in cases for which such local-
ization is expected to be difficult as determined through
presurgical lymphoscintigraphy. Use of both technologies
appears to add 10–15 min to the surgical time—an addition
that we consider appropriate in view of the associated
improvement in sentinel node retrieval.
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